-
1
-
-
7444259675
-
A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer
-
DOI 10.1056/NEJMoa032312
-
PE Goss JN Ingle S Martino NJ Robert HB Muss MJ Piccart M Castiglione D Tu LE Shepherd KI Pritchard, et al. 2003 A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer N Engl J Med 349 19 1793 1802 14551341 10.1056/NEJMoa032312 1:CAS:528:DC%2BD3sXosl2gtbc%3D (Pubitemid 37362955)
-
(2003)
New England Journal of Medicine
, vol.349
, Issue.19
, pp. 1793-1802
-
-
Goss, P.E.1
Ingle, J.N.2
Martino, S.3
Robert, N.J.4
Muss, H.B.5
Piccart, M.J.6
Castiglione, M.7
Tu, D.8
Shepherd, L.E.9
Pritchard, K.I.10
Livingston, R.B.11
Davidson, N.E.12
Norton, L.13
Perez, E.A.14
Abrams, J.S.15
Therasse, P.16
Palmer, M.J.17
Pater, J.L.18
-
2
-
-
10744223655
-
A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer
-
DOI 10.1056/NEJMoa040331
-
RC Coombes E Hall LJ Gibson R Paridaens J Jassem T Delozier SE Jones I Alvarez G Bertelli O Ortmann, et al. 2004 A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer N Engl J Med 350 11 1081 1092 15014181 10.1056/NEJMoa040331 1:CAS:528:DC%2BD2cXitV2qtbc%3D (Pubitemid 38298988)
-
(2004)
New England Journal of Medicine
, vol.350
, Issue.11
, pp. 1081-1092
-
-
Coombes, R.C.1
Hall, E.2
Gibson, L.J.3
Paridaens, R.4
Jassem, J.5
Delozier, T.6
Jones, S.E.7
Alvarez, I.8
Bertelli, G.9
Ortmann, O.10
Coates, A.S.11
Bajetta, E.12
Dodwell, D.13
Coleman, R.E.14
Fallowfield, L.J.15
Mickiewicz, E.16
Andersen, J.17
Lonning, P.E.18
Cocconi, G.19
Stewart, A.20
Stuart, N.21
Snowdon, C.F.22
Carpentieri, M.23
Massimini, G.24
Bliss, J.M.25
more..
-
3
-
-
0141762741
-
The role of aromatase inhibitors in the treatment of metastatic breast cancer
-
H Mouridsen M Gershanovich 2003 The role of aromatase inhibitors in the treatment of metastatic breast cancer Semin Oncol 30 4 Suppl 14 33 45 14513435 10.1016/S0093-7754(03)00301-4 1:CAS:528:DC%2BD3sXovFWitrs%3D (Pubitemid 37169772)
-
(2003)
Seminars in Oncology
, vol.30
, Issue.SUPPL. 14
, pp. 33-45
-
-
Mouridsen, H.1
Gershanovich, M.2
-
4
-
-
77954934986
-
Phase II parallel group study showing comparable efficacy between premenopausal metastatic breast cancer patients treated with letrozole plus goserelin and postmenopausal patients treated with letrozole alone as first-line hormone therapy
-
20421538 10.1200/JCO.2009.26.5884 1:CAS:528:DC%2BC3cXoslyktL0%3D
-
IH Park J Ro KS Lee EA Kim Y Kwon BH Nam SY Jung S Lee SW Kim HS Kang 2010 Phase II parallel group study showing comparable efficacy between premenopausal metastatic breast cancer patients treated with letrozole plus goserelin and postmenopausal patients treated with letrozole alone as first-line hormone therapy J Clin Oncol 28 16 2705 2711 20421538 10.1200/JCO.2009.26.5884 1:CAS:528:DC%2BC3cXoslyktL0%3D
-
(2010)
J Clin Oncol
, vol.28
, Issue.16
, pp. 2705-2711
-
-
Park, I.H.1
Ro, J.2
Lee, K.S.3
Kim, E.A.4
Kwon, Y.5
Nam, B.H.6
Jung, S.Y.7
Lee, S.8
Kim, S.W.9
Kang, H.S.10
-
5
-
-
0343584508
-
Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: Results of a phase III study of the international letrozole breast cancer group
-
H Mouridsen M Gershanovich Y Sun R Perez-Carrion C Boni A Monnier J Apffelstaedt R Smith HP Sleeboom F Janicke, et al. 2001 Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the international Letrozole breast cancer group J Clin Oncol 19 10 2596 2606 11352951 1:CAS:528:DC%2BD3MXkt1OmurY%3D (Pubitemid 32451796)
-
(2001)
Journal of Clinical Oncology
, vol.19
, Issue.10
, pp. 2596-2606
-
-
Mouridsen, H.1
Gershanovich, M.2
Sun, Y.3
Perez-Carrion, R.4
Boni, C.5
Monnier, A.6
Apffelstaedt, J.7
Smith, R.8
Sleeboom, H.P.9
Janicke, F.10
Pluzanska, A.11
Dank, M.12
Becquart, D.13
Bapsy, P.P.14
Salminen, E.15
Snyder, R.16
Lassus, M.17
Verbeek, J.A.18
Staffler, B.19
Chaudri-Ross, H.A.20
Dugan, M.21
more..
-
6
-
-
0034669484
-
Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: Results of a North American multicenter randomized trial. Arimidex study group
-
11078488 1:CAS:528:DC%2BD3cXos1Orsbw%3D
-
JM Nabholtz A Buzdar M Pollak W Harwin G Burton A Mangalik M Steinberg A Webster M von Euler 2000 Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial. Arimidex study group J Clin Oncol 18 22 3758 3767 11078488 1:CAS:528:DC%2BD3cXos1Orsbw%3D
-
(2000)
J Clin Oncol
, vol.18
, Issue.22
, pp. 3758-3767
-
-
Nabholtz, J.M.1
Buzdar, A.2
Pollak, M.3
Harwin, W.4
Burton, G.5
Mangalik, A.6
Steinberg, M.7
Webster, A.8
Von Euler, M.9
-
7
-
-
41149110156
-
Overcoming endocrine resistance in breast cancer - Are signal transduction inhibitors the answer?
-
DOI 10.1007/s10549-007-9606-8
-
PL Bedard OC Freedman A Howell M Clemons 2008 Overcoming endocrine resistance in breast cancer: are signal transduction inhibitors the answer? Breast Cancer Res Treat 108 3 307 317 18351454 10.1007/s10549-007-9606-8 1:CAS:528:DC%2BD1cXjsFGisb4%3D (Pubitemid 351431070)
-
(2008)
Breast Cancer Research and Treatment
, vol.108
, Issue.3
, pp. 307-317
-
-
Bedard, P.L.1
Freedman, O.C.2
Howell, A.3
Clemons, M.4
-
8
-
-
61649113970
-
Regulation of aromatase expression in breast cancer tissue
-
19250199 10.1111/j.1749-6632.2009.03705.x 1:CAS:528:DC%2BD1MXktFKltr4%3D
-
SE Bulun Z Lin H Zhao M Lu S Amin S Reierstad D Chen 2009 Regulation of aromatase expression in breast cancer tissue Ann NY Acad Sci 1155 121 131 19250199 10.1111/j.1749-6632.2009.03705.x 1:CAS:528:DC%2BD1MXktFKltr4%3D
-
(2009)
Ann NY Acad Sci
, vol.1155
, pp. 121-131
-
-
Bulun, S.E.1
Lin, Z.2
Zhao, H.3
Lu, M.4
Amin, S.5
Reierstad, S.6
Chen, D.7
-
9
-
-
38849180907
-
Haplotype analyses of CYP19A1 gene variants and breast cancer risk: Results from the Shanghai Breast Cancer Study
-
DOI 10.1158/1055-9965.EPI-07-0688
-
Q Cai N Kataoka C Li W Wen JR Smith YT Gao XO Shu W Zheng 2008 Haplotype analyses of CYP19A1 gene variants and breast cancer risk: results from the Shanghai breast cancer study Cancer Epidemiol Biomarkers Prev 17 1 27 32 18199708 10.1158/1055-9965.EPI-07-0688 1:CAS:528:DC%2BD1cXmt12gsA%3D%3D (Pubitemid 351196270)
-
(2008)
Cancer Epidemiology Biomarkers and Prevention
, vol.17
, Issue.1
, pp. 27-32
-
-
Cai, Q.1
Kataoka, N.2
Li, C.3
Wen, W.4
Smith, J.R.5
Gao, Y.-T.6
Xiao, O.S.7
Zheng, W.8
-
10
-
-
10744231844
-
Association of genetic polymorphisms in CYP19 and CYP1A1 with the oestrogen receptor-positive breast cancer risk
-
DOI 10.1016/j.ejca.2003.08.017
-
Y Miyoshi A Ando S Hasegawa M Ishitobi J Yamamura N Irahara Y Tanji T Taguchi Y Tamaki S Noguchi 2003 Association of genetic polymorphisms in CYP19 and CYP1A1 with the oestrogen receptor-positive breast cancer risk Eur J Cancer 39 17 2531 2537 14602139 10.1016/j.ejca.2003.08.017 1:CAS:528: DC%2BD3sXos1KisLw%3D (Pubitemid 37340166)
-
(2003)
European Journal of Cancer
, vol.39
, Issue.17
, pp. 2531-2537
-
-
Miyoshi, Y.1
Ando, A.2
Hasegawa, S.3
Ishitobi, M.4
Yamamura, J.5
Irahara, N.6
Tanji, Y.7
Taguchi, T.8
Tamaki, Y.9
Noguchi, S.10
-
11
-
-
52949088650
-
Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients
-
18049890 10.1007/s10549-007-9822-2 1:CAS:528:DC%2BD1cXhtFOjtrbE
-
PA Fasching CR Loehberg PL Strissel MP Lux MR Bani M Schrauder S Geiler K Ringleff S Oeser S Weihbrecht, et al. 2008 Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients Breast Cancer Res Treat 112 1 89 98 18049890 10.1007/s10549-007-9822-2 1:CAS:528:DC%2BD1cXhtFOjtrbE
-
(2008)
Breast Cancer Res Treat
, vol.112
, Issue.1
, pp. 89-98
-
-
Fasching, P.A.1
Loehberg, C.R.2
Strissel, P.L.3
Lux, M.P.4
Bani, M.R.5
Schrauder, M.6
Geiler, S.7
Ringleff, K.8
Oeser, S.9
Weihbrecht, S.10
-
12
-
-
33845330613
-
Genetic polymorphisms of the CYP19A1 gene and breast cancer survival
-
DOI 10.1158/1055-9965.EPI-06-0464
-
JR Long N Kataoka XO Shu W Wen YT Gao Q Cai W Zheng 2006 Genetic polymorphisms of the CYP19A1 gene and breast cancer survival Cancer Epidemiol Biomarkers Prev 15 11 2115 2122 17119036 10.1158/1055-9965.EPI-06-0464 1:CAS:528:DC%2BD28Xht1aisrbO (Pubitemid 44877034)
-
(2006)
Cancer Epidemiology Biomarkers and Prevention
, vol.15
, Issue.11
, pp. 2115-2122
-
-
Long, J.-R.1
Kataoka, N.2
Shu, X.-O.3
Wen, W.4
Gao, Y.-T.5
Cai, Q.6
Zheng, W.7
-
13
-
-
28244452912
-
Human aromatase: Gene resequencing and functional genomics
-
DOI 10.1158/0008-5472.CAN-05-1218
-
CX Ma AA Adjei OE Salavaggione J Coronel L Pelleymounter L Wang BW Eckloff D Schaid ED Wieben RM Weinshilboum 2005 Human aromatase: gene resequencing and functional genomics Cancer Res 65 23 11071 11082 16322257 10.1158/0008-5472.CAN-05-1218 1:CAS:528:DC%2BD2MXht1Kjsr3F (Pubitemid 41713378)
-
(2005)
Cancer Research
, vol.65
, Issue.23
, pp. 11071-11082
-
-
Ma, C.X.1
Adjei, A.A.2
Salavaggione, O.E.3
Coronel, J.4
Pelleymounter, L.5
Wang, L.6
Eckloff, B.W.7
Schaid, D.8
Wieben, E.D.9
Adjei, A.A.10
Weinshilboum, R.M.11
-
14
-
-
38949105895
-
A single-nucleotide polymorphismin the aromatase gene is associated with the efficacy of the aromatase inhibitor letrozole in advanced breast carcinoma
-
DOI 10.1158/1078-0432.CCR-07-1923
-
R Colomer M Monzo I Tusquets J Rifa JM Baena A Barnadas L Calvo F Carabantes C Crespo M Munoz, et al. 2008 A single-nucleotide polymorphism in the aromatase gene is associated with the efficacy of the aromatase inhibitor letrozole in advanced breast carcinoma Clin Cancer Res 14 3 811 816 18245543 10.1158/1078-0432.CCR-07-1923 1:CAS:528:DC%2BD1cXhsFykt7g%3D (Pubitemid 351231164)
-
(2008)
Clinical Cancer Research
, vol.14
, Issue.3
, pp. 811-816
-
-
Colomer, R.1
Monzo, M.2
Tusquets, I.3
Rifa, J.4
Baena, J.M.5
Barnadas, A.6
Calvo, L.7
Carabantes, F.8
Crespo, C.9
Munoz, M.10
Llombart, A.11
Plazaola, A.12
Artells, R.13
Gilabert, M.14
Lloveras, B.15
Alba, E.16
-
15
-
-
0034594628
-
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
-
10655437 10.1093/jnci/92.3.205 1:STN:280:DC%2BD3c7it1Gitg%3D%3D
-
P Therasse SG Arbuck EA Eisenhauer J Wanders RS Kaplan L Rubinstein J Verweij M Van Glabbeke AT van Oosterom MC Christian, et al. 2000 New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 3 205 216 10655437 10.1093/jnci/92.3.205 1:STN:280:DC%2BD3c7it1Gitg%3D%3D
-
(2000)
J Natl Cancer Inst
, vol.92
, Issue.3
, pp. 205-216
-
-
Therasse, P.1
Arbuck, S.G.2
Eisenhauer, E.A.3
Wanders, J.4
Kaplan, R.S.5
Rubinstein, L.6
Verweij, J.7
Van Glabbeke, M.8
Van Oosterom, A.T.9
Christian, M.C.10
-
16
-
-
10744228140
-
CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment
-
DOI 10.1016/S1053-4296(03)00031-6
-
A Trotti AD Colevas A Setser V Rusch D Jaques V Budach C Langer B Murphy R Cumberlin CN Coleman, et al. 2003 CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment Semin Radiat Oncol 13 3 176 181 12903007 10.1016/S1053-4296(03)00031-6 (Pubitemid 36962641)
-
(2003)
Seminars in Radiation Oncology
, vol.13
, Issue.3
, pp. 176-181
-
-
Trotti, A.1
Colevas, A.D.2
Setser, A.3
Rusch, V.4
Jaques, D.5
Budach, V.6
Langer, C.7
Murphy, B.8
Cumberlin, R.9
Coleman, C.N.10
Rubin, P.11
-
17
-
-
59649090821
-
SNP genotyping using the Sequenom MassARRAY iPLEX platform
-
2.12.1-2.12.16
-
Gabriel S, Ziaugra L, Tabbaa D (2009) SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr Protoc Hum Genet 60:2.12.1-2.12.16
-
(2009)
Curr Protoc Hum Genet
, vol.60
-
-
Gabriel, S.1
Ziaugra, L.2
Tabbaa, D.3
-
18
-
-
0029150074
-
A comparison of linkage disequilibrium measures for fine-scale mapping
-
8666377 10.1006/geno.1995.9003 1:CAS:528:DyaK2MXovVSls7s%3D
-
B Devlin N Risch 1995 A comparison of linkage disequilibrium measures for fine-scale mapping Genomics 29 2 311 322 8666377 10.1006/geno.1995.9003 1:CAS:528:DyaK2MXovVSls7s%3D
-
(1995)
Genomics
, vol.29
, Issue.2
, pp. 311-322
-
-
Devlin, B.1
Risch, N.2
-
19
-
-
0036138183
-
Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms
-
DOI 10.1086/338446
-
T Niu ZS Qin X Xu JS Liu 2002 Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms Am J Hum Genet 70 1 157 169 11741196 10.1086/338446 1:CAS:528:DC%2BD38XlvVKgtQ%3D%3D (Pubitemid 34031705)
-
(2002)
American Journal of Human Genetics
, vol.70
, Issue.1
, pp. 157-169
-
-
Niu, T.1
Qin, Z.S.2
Xu, X.3
Liu, J.S.4
-
20
-
-
77649178123
-
A polymorphism at the 3′-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole
-
Garcia-Casado Z, Guerrero-Zotano A, Llombart-Cussac A, Calatrava A, Fernandez-Serra A, Ruiz-Simon A, Gavila J, Climent MA, Almenar S, Cervera-Deval J et al (2010) A polymorphism at the 3′-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole. BMC Cancer 10:36
-
(2010)
BMC Cancer
, vol.10
, pp. 36
-
-
Garcia-Casado, Z.1
Guerrero-Zotano, A.2
Llombart-Cussac, A.3
Calatrava, A.4
Fernandez-Serra, A.5
Ruiz-Simon, A.6
Gavila, J.7
Ma, C.8
Almenar, S.9
Cervera-Deval, J.10
-
21
-
-
33750585962
-
Clinical outcomes of ethnic minority women in MA.17: A trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancer
-
DOI 10.1093/annonc/mdl177
-
B Moy D Tu JL Pater JN Ingle LE Shepherd TJ Whelan PE Goss 2006 Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancer Ann Oncol 17 11 1637 1643 16936184 10.1093/annonc/mdl177 1:STN:280:DC%2BD28jhsFWmuw%3D%3D (Pubitemid 44680883)
-
(2006)
Annals of Oncology
, vol.17
, Issue.11
, pp. 1637-1643
-
-
Moy, B.1
Tu, D.2
Pater, J.L.3
Ingle, J.N.4
Shepherd, L.E.5
Whelan, T.J.6
Goss, P.E.7
-
22
-
-
0038778339
-
Regulation of CYP19 gene expression in primary human osteoblasts: Effects of vitamin D and other treatments
-
DOI 10.1530/eje.0.1480519
-
A Enjuanes N Garcia-Giralt A Supervia X Nogues L Mellibovsky J Carbonell D Grinberg S Balcells A Diez-Perez 2003 Regulation of CYP19 gene expression in primary human osteoblasts: effects of vitamin D and other treatments Eur J Endocrinol 148 5 519 526 12720534 10.1530/eje.0.1480519 1:CAS:528: DC%2BD3sXktVGjs7k%3D (Pubitemid 36622158)
-
(2003)
European Journal of Endocrinology
, vol.148
, Issue.5
, pp. 519-526
-
-
Enjuanes, A.1
Garcia-Giralt, N.2
Supervia, A.3
Nogues, X.4
Mellibovsky, L.5
Carbonell, J.6
Grinberg, D.7
Balcells, S.8
Diez-Perez, A.9
-
23
-
-
29644437490
-
Functional analysis of the I.3, I.6, pII and I.4 promoters of CYP19 (aromatase) gene in human osteoblasts and their role in vitamin D and dexamethasone stimulation
-
DOI 10.1530/eje.1.02032
-
A Enjuanes N Garcia-Giralt A Supervia X Nogues S Ruiz-Gaspa M Bustamante L Mellibovsky D Grinberg S Balcells A Diez-Perez 2005 Functional analysis of the I.3, I.6, pII and I.4 promoters of CYP19 (aromatase) gene in human osteoblasts and their role in vitamin D and dexamethasone stimulation Eur J Endocrinol 153 6 981 988 16322405 10.1530/eje.1.02032 1:CAS:528:DC%2BD28XjtVWksw%3D%3D (Pubitemid 43020250)
-
(2005)
European Journal of Endocrinology
, vol.153
, Issue.6
, pp. 981-988
-
-
Enjuanes, A.1
Garcia-Giralt, N.2
Supervia, A.3
Nogues, X.4
Ruiz-Gaspa, S.5
Bustamante, M.6
Mellibovsky, L.7
Grinberg, D.8
Balcells, S.9
Diez-Perez, A.10
-
24
-
-
2942683102
-
Polymorphisms associated with circulating sex hormone levels in postmenopausal women
-
AM Dunning M Dowsett CS Healey L Tee RN Luben E Folkerd KL Novik L Kelemen S Ogata PD Pharoah 2004 Polymorphisms associated with circulating sex hormone levels in postmenopausal women J Natl Cancer Inst 96 12 936 945 15199113 10.1093/jnci/djh167 1:CAS:528:DC%2BD2cXltVWmtb8%3D (Pubitemid 38868140)
-
(2004)
Journal of the National Cancer Institute
, vol.96
, Issue.12
, pp. 936-945
-
-
Dunning, A.M.1
Dowsett, M.2
Healey, C.S.3
Tee, L.4
Luben, R.N.5
Folkerd, E.6
Novik, K.L.7
Kelemen, L.8
Ogata, S.9
Pharoah, P.D.P.10
Easton, D.F.11
Day, N.E.12
Ponder, B.A.J.13
-
25
-
-
9144240392
-
Association of CYP17, CYP19, CYP1B1, and COMT Polymorphisms with Serum and Urinary Sex Hormone Concentrations in Postmenopausal Women
-
DOI 10.1158/1055-9965.EPI-03-0026
-
SS Tworoger J Chubak EJ Aiello CM Ulrich C Atkinson JD Potter Y Yasui PL Stapleton JW Lampe FM Farin 2004 Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women Cancer Epidemiol Biomarkers Prev 13 1 94 101 14744739 10.1158/1055-9965.EPI-03-0026 1:CAS:528:DC%2BD2cXmsVWmtA%3D%3D (Pubitemid 38116626)
-
(2004)
Cancer Epidemiology Biomarkers and Prevention
, vol.13
, Issue.1
, pp. 94-101
-
-
Tworoger, S.S.1
Chubak, J.2
Aiello, E.J.3
Ulrich, C.M.4
Atkinson, C.5
Potter, J.D.6
Yasui, Y.7
Stapleton, P.L.8
Lampe, J.W.9
Farin, F.M.10
Stanczyk, F.Z.11
McTiernan, A.12
-
26
-
-
0036467847
-
Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study
-
DOI 10.1200/JCO.20.3.751
-
J Geisler B Haynes G Anker M Dowsett PE Lonning 2002 Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study J Clin Oncol 20 3 751 757 11821457 10.1200/JCO.20.3.751 1:CAS:528:DC%2BD38XhsVGmt7Y%3D (Pubitemid 34111382)
-
(2002)
Journal of Clinical Oncology
, vol.20
, Issue.3
, pp. 751-757
-
-
Geisler, J.1
Haynes, B.2
Anker, G.3
Dowsett, M.4
Lonning, P.E.5
-
27
-
-
43249113162
-
Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer
-
18375896 10.1200/JCO.2007.13.9279 1:CAS:528:DC%2BD1cXltlWhsrk%3D
-
JM Dixon L Renshaw O Young J Murray EJ Macaskill M McHugh E Folkerd DA Cameron RP A'Hern M Dowsett 2008 Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer J Clin Oncol 26 10 1671 1676 18375896 10.1200/JCO.2007.13.9279 1:CAS:528:DC%2BD1cXltlWhsrk%3D
-
(2008)
J Clin Oncol
, vol.26
, Issue.10
, pp. 1671-1676
-
-
Dixon, J.M.1
Renshaw, L.2
Young, O.3
Murray, J.4
MacAskill, E.J.5
McHugh, M.6
Folkerd, E.7
Cameron, D.A.8
A'hern, R.P.9
Dowsett, M.10
-
28
-
-
0029887272
-
Presence of alternatively spliced transcripts of aromatase gene in human breast cancer
-
DOI 10.1210/jc.81.6.2344
-
T Utsumi N Harada M Maruta Y Takagi 1996 Presence of alternatively spliced transcripts of aromatase gene in human breast cancer J Clin Endocrinol Metab 81 6 2344 2349 8964875 10.1210/jc.81.6.2344 1:CAS:528:DyaK28XjsFyktrc%3D (Pubitemid 26175966)
-
(1996)
Journal of Clinical Endocrinology and Metabolism
, vol.81
, Issue.6
, pp. 2344-2349
-
-
Utsumi, T.1
Harada, N.2
Maruta, M.3
Takagi, Y.4
-
29
-
-
0030266161
-
Aromatase gene expression and its exon I usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription-polymerase chain reaction
-
DOI 10.1016/S0960-0760(96)00100-8, PII S0960076096001008
-
C Zhou D Zhou J Esteban J Murai PK Siiteri S Wilczynski S Chen 1996 Aromatase gene expression and its exon I usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription-polymerase chain reaction J Steroid Biochem Mol Biol 59 2 163 171 9010331 10.1016/S0960-0760(96)00100-8 1:CAS:528:DyaK2sXos1Cmsw%3D%3D (Pubitemid 27036268)
-
(1996)
Journal of Steroid Biochemistry and Molecular Biology
, vol.59
, Issue.2
, pp. 163-171
-
-
Zhou, C.1
Zhou, D.2
Esteban, J.3
Murai, J.4
Siiteri, P.K.5
Wilczynski, S.6
Chen, S.7
-
30
-
-
75149159605
-
Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors
-
20048079 10.1158/0008-5472.CAN-09-3224 1:CAS:528:DC%2BC3cXltVSn
-
L Wang KA Ellsworth I Moon LL Pelleymounter BW Eckloff YN Martin BL Fridley GD Jenkins A Batzler VJ Suman, et al. 2010 Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors Cancer Res 70 1 319 328 20048079 10.1158/0008-5472.CAN-09-3224 1:CAS:528:DC%2BC3cXltVSn
-
(2010)
Cancer Res
, vol.70
, Issue.1
, pp. 319-328
-
-
Wang, L.1
Ellsworth, K.A.2
Moon, I.3
Pelleymounter, L.L.4
Eckloff, B.W.5
Martin, Y.N.6
Fridley, B.L.7
Jenkins, G.D.8
Batzler, A.9
Suman, V.J.10
|